Synthetic DNA Market Summary
The global synthetic DNA market size was valued at USD 4.1 billion in 2025 and is projected to grow from USD 4.8 billion in 2026 to USD 14.2 billion by 2033, at a CAGR of 16.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 39.8% in 2025. Investment in synthetic DNA development, advances in targeted delivery technologies, and growing adoption of programmable cell-engineering approaches for precision medicine.
Global Synthetic DNA Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global synthetic DNA industry based on product & services, technology, application, end use, and region.
- Product & Service Outlook (Revenue, USD Billion, 2021 - 2033)
- Oligonucleotide Synthesis
- Gene Synthesis
- Plasmid DNA
- DNA Libraries
- Other Synthetic DNA Products & Services
- Technology Outlook (Revenue, USD Billion, 2021 - 2033)
- Chemical/Solid-Phase Synthesis
- Enzymatic DNA Synthesis
- Array-/Chip-Based DNA Synthesis
- Others
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Research & Development
- Diagnostics
- Therapeutics & Vaccines
- Synthetic Biology (incl. Industrial & Agri-Food Biotech)
- Other Applications
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CROs & CDMOs
- Diagnostic Laboratories & Companies
- Agricultural & Industrial Biotechnology Companies
- Government & Other Research Organizations
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait